as on February 7, 2026 at 7:59 am IST
Day's Low
Day's High
10.61%
Downside
46.93%
Upside
52 Week's Low
52 Week's High
69.84%
Downside
1780.45%
Upside
Check Liminatus Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$145.2M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Liminatus Pharma Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $145.2M | NA | NA | 0.00% | |
| BUY | $122.3B | 122.02% | 33.56 | 31.35% | |
| BUY | $47.7B | 98.75% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 57.42% | 18.28 | 32.13% |
Investment in Liminatus Pharma Inc Shares on INDmoney has grown by 3300.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:3300.00% versus previous 30 day period
Search interest for Liminatus Pharma Inc Stock has increased by 735% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:735% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, LIMN stock has moved up by 234.4%
| Organisation | Liminatus Pharma Inc |
| Headquarters | 6 Centerpointe Drive, La Palma, CA, United States, 90623 |
| CEO | Mr. Chris Kim J.D., L.L.M. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Chris Kim J.D., L.L.M. | CEO & Chairman |
Mr. Scott Dam | Chief Financial Officer |
Dr. Beom Kyu Choi | Chief Technology Officer & Member of Scientific Advisory Board |
Dr. Byong Chul Yoo Ph.D. | Chief Science Officer & Member of Scientific Advisory Board |
Dr. Sang-jin Lee Ph.D. | Head of Research & Development and Member of Scientific Advisory Board |
Liminatus Pharma Inc share price today is $1.79 as on at the close of the market. Liminatus Pharma Inc share today touched a day high of $2.63 and a low of $1.6.
Liminatus Pharma Inc share touched a 52 week high of $33.66 on and a 52 week low of $0.54 on . Liminatus Pharma Inc stock price today i.e. is closed at $1.79,which is 94.68% down from its 52 week high and 231.54% up from its 52 week low.
Liminatus Pharma Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Liminatus Pharma Inc (LIMN) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Liminatus Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Liminatus Pharma Inc share’s latest price of $1.79 as on February 7, 2026 at 2:29 am IST, you will get 5.5866 shares of Liminatus Pharma Inc. Learn more about
fractional shares .